Importance of the Renal Ion Channel TRPM6 in the Circadian Secretion of Renin to Raise Blood Pressure
Overview
Affiliations
Blood pressure has a daily pattern, with higher values in the active period. Its elevation at the onset of the active period substantially increases the risk of fatal cardiovascular events. Renin secretion stimulated by renal sympathetic neurons is considered essential to this process; however, its regulatory mechanism remains largely unknown. Here, we show the importance of transient receptor potential melastatin-related 6 (TRPM6), a Mg-permeable cation channel, in augmenting renin secretion in the active period. TRPM6 expression is significantly reduced in the distal convoluted tubule of hypotensive Cnnm2-deficient mice. We generate kidney-specific Trpm6-deficient mice and observe a decrease in blood pressure and a disappearance of its circadian variation. Consistently, renin secretion is not augmented in the active period. Furthermore, renin secretion after pharmacological activation of β-adrenoreceptor, the target of neuronal stimulation, is abrogated, and the receptor expression is decreased in renin-secreting cells. These results indicate crucial roles of TRPM6 in the circadian regulation of blood pressure.
Genetic drivers of age-related changes in urinary magnesium excretion.
van Megen W, de Baaij J, Churchill G, Devuyst O, Hoenderop J, Korstanje R Physiol Genomics. 2024; 56(9):634-647.
PMID: 39037434 PMC: 11460537. DOI: 10.1152/physiolgenomics.00119.2023.
Magnesium for disease treatment and prevention: emerging mechanisms and opportunities.
Gao Q, Cil O Trends Pharmacol Sci. 2024; 45(8):708-722.
PMID: 39019764 PMC: 11892326. DOI: 10.1016/j.tips.2024.06.004.
TRPM channels in health and disease.
Chubanov V, Kottgen M, Touyz R, Gudermann T Nat Rev Nephrol. 2023; 20(3):175-187.
PMID: 37853091 DOI: 10.1038/s41581-023-00777-y.
CBGA ameliorates inflammation and fibrosis in nephropathy.
Suzuki S, Fleig A, Penner R Sci Rep. 2023; 13(1):6341.
PMID: 37072467 PMC: 10113213. DOI: 10.1038/s41598-023-33507-2.
Bignon Y, Wigger L, Ansermet C, Weger B, Lagarrigue S, Centeno G J Clin Invest. 2023; 133(8).
PMID: 36862511 PMC: 10104904. DOI: 10.1172/JCI167133.